AI-generated summary
The authors report a pilot study of 830 nm LED phototherapy in 65 injured university athletes who completed full treatment and follow-up. Average return to play was reported as 9.6 days, compared with a historically anticipated 19.23 days, with 78.5% of a separate satisfaction survey reporting being very satisfied or satisfied. The study had no control group and relied on subjective assessments, so the authors call for further controlled studies.
- Participants
- 65
- Who or what was studied
- Injured university athletes treated with 830 nm LED phototherapy, with 65 subjects providing full treatment and follow-up data
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The study was a pilot with subjective assessments and no control group, and the return-to-play comparison used historically based anticipated recovery times.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Phototherapy, Pilot study, Visual analogue scale, Near-infrared, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.